Subscribe to this collection to receive daily e-mail notification of new additions

Issue Date	Title	Author(s)
2020-02	Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy	Murugesan, Sankaranarayanan
2020-05	Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivatives	Murugesan, Sankaranarayanan
2020-06	A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery	Murugesan, Sankaranarayanan
2020-07	Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents	Murugesan, Sankaranarayanan
2020	Leishmaniasis is the most widespread pathogenic disease in several countries. Currently, no effective vaccines are available, and the control of Leishmaniasis primarily relies on decade-old chemotherapy. The treatment for the Leishmaniasis is not up to the mark. Current therapy for Leishmaniasis is ancient and requires hospitalization for the administration. These medications are also highly toxic and resistant. β-carboline, a natural indole containing alkaloid, holds a vital position in the field of medicinal chemistry with a diversified pharmacological action. The current review focuses mainly on the anti-leishmanial effects of β-carboline analogs and their synthetic strategies, structural activity relationship studies (SAR). The past ten years alterations unveiled by β-carboline analogs present in phytoconstituents and various derivatives of synthesized analogs with the mechanism of action were briefly shortlisted and illustrated	Murugesan, Sankaranarayanan
2020-09	Review article| Volume 6, ISSUE 9, e04916, September 2020 PDF [2 MB] Figures Save Share Reprints Request Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update	Murugesan, Sankaranarayanan
2020	Coumarin-Oxadiazole Derivatives: Synthesis and Pharmacological Properties	Murugesan, Sankaranarayanan
2020-10	Synthesis, biological evaluation, molecular docking, molecular dynamics and DFT studies of quinoline-fluoroproline amide hybrids	Murugesan, Sankaranarayanan
2020-07	Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities	Murugesan, Sankaranarayanan
2020-11	Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19	Murugesan, Sankaranarayanan
2020	Sequential multicomponent catalytic synthesis of pyrrole-3-carboxaldehydes: Evaluation for antibacterial and antifungal activities along with docking studies	Murugesan, Sankaranarayanan
2020	Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents	Murugesan, Sankaranarayanan
2021-01	Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges	Murugesan, Sankaranarayanan
2021-09	Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents	Murugesan, Sankaranarayanan
2021-04	1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design	Murugesan, Sankaranarayanan
2021-11	Pharmacoinformatics-based investigation of bioactive compounds of Rasam (South Indian recipe) against human cancer	Murugesan, Sankaranarayanan
2021-12	Novel phenanthridine amide analogs as potential anti-leishmanial agents: In vitro and in silico insights	Murugesan, Sankaranarayanan
2022-12	Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach	Murugesan, Sankaranarayanan
2021	Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies	Murugesan, Sankaranarayanan
2020-09	Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases	Murugesan, Sankaranarayanan